Kusajili – Clinical trials directory

Result of your search per sponsor: Dr Bruno Sangro, MD, PhD

Woman and Man Max 99 years
Dr Bruno Sangro, MD, PhD Update Il y a 4 ans

SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma This study is open to patients with primary HCC who cannot be treated by potentially curative treatment modalities, such as surgical resection, liver transplantation or percutaneous ablati...

Country None
organs None
Specialty None

Closed trial

More information